How many institutions held OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share in Q4 2024?

12 institutional investors reported OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share for Q4 2024. Use the holders table for investor-level position and value details.

Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (OCS)

Q: What does CUSIP H5870P102 represent in this 13F holders report?

CUSIP H5870P102 is the security identifier for OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share used to aggregate holder disclosures.

CUSIP: H5870P102

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Ordinary Shares, par value CHF 0.01 per share
Shares outstanding: 58,900,797
Total 13F shares: 3,493,543
Share change: +480,340
Total reported value: $59,378,651
Reported price per share: $17.00
Number of holders: 12
Value change: +$8,163,517
Number of buys: 8
Number of sells: 1

Security key

H5870P102

Report period

Q4 2024

Institutions

Top holders

OCS full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 Oculis Holding AG SEC filings Oculis Holding AG company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP H5870P102

Newer quarter: Q1 2025 Previous quarter: Q3 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of OCS - Oculis Holding AG - Ordinary Shares, par value CHF 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Pivotal bioVenture Partne...

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2024

13F Lead comparable stake: 2.7% Showing 1-6 of 15 holder rows.

Rank 1 holder

Pivotal bioVenture Partners Investment Advisor LLC

13F

Ownership: 2.7%
Position: $19.57M

13F

Rank 2 holder

Aberdeen Group plc

13F

Ownership: 1.4%
Position: $10.06M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Pivotal bioVenture Partners Investment Advisor LLC	13F Company 13F	2.7%	$19,565,955 1,595,918 shares	—	30 Sep 2024
Aberdeen Group plc	13F Company 13F	1.4%	$10,064,083 820,553 shares	—	30 Sep 2024
Nan Fung Group Holdings Ltd	13F Company 13F	0.74%	$5,349,994 436,378 shares	—	30 Sep 2024
Lombard Odier SCmA Compagnie	13F Individual 13F	0.16%	$1,174,374 95,750 shares	—	30 Sep 2024
BANK OF AMERICA CORP /DE/	13F Company 13F	0.03%	$224,517 18,313 shares	—	30 Sep 2024
UBS Group AG	13F Company 13F	0.03%	$217,947 17,777 shares	—	30 Sep 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,493,543

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend